Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
144.38
Dollar change
-2.59
Percentage change
-1.76
%
IndexDJIA, S&P 500 P/E20.80 EPS (ttm)6.94 Insider Own0.16% Shs Outstand2.41B Perf Week-4.55%
Market Cap347.48B Forward P/E13.18 EPS next Y10.96 Insider Trans-1.74% Shs Float2.40B Perf Month-1.20%
Income17.49B PEG4.00 EPS next Q2.71 Inst Own71.87% Short Float0.73% Perf Quarter-10.31%
Sales89.66B P/S3.88 EPS this Y7.35% Inst Trans-0.39% Short Ratio2.35 Perf Half Y-5.32%
Book/sh29.09 P/B4.96 EPS next Y2.88% ROA9.15% Short Interest17.43M Perf Year-6.50%
Cash/sh10.89 P/C13.25 EPS next 5Y5.20% ROE23.91% 52W Range143.13 - 175.97 Perf YTD-7.89%
Dividend Est.4.81 (3.33%) P/FCF18.58 EPS past 5Y-0.27% ROI18.39% 52W High-17.95% Beta0.53
Dividend TTM4.81 (3.33%) Quick Ratio0.94 Sales past 5Y1.31% Gross Margin68.49% 52W Low0.87% ATR (14)2.45
Dividend Ex-DateMay 20, 2024 Current Ratio1.17 EPS Y/Y TTM44.66% Oper. Margin25.66% RSI (14)35.82 Volatility1.99% 1.45%
Employees131900 Debt/Eq0.48 Sales Y/Y TTM-6.90% Profit Margin19.51% Recom2.17 Target Price172.65
Option/ShortYes / Yes LT Debt/Eq0.36 EPS Q/Q5231.80% Payout84.93% Rel Volume1.40 Prev Close146.97
Sales Surprise-0.08% EPS Surprise2.04% Sales Q/Q-13.55% EarningsApr 16 BMO Avg Volume7.43M Price144.38
SMA20-3.90% SMA50-4.58% SMA200-7.68% Trades Volume10,413,946 Change-1.76%
Date Action Analyst Rating Change Price Target Change
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Mar-29-23Initiated UBS Neutral $164
Mar-01-23Initiated Guggenheim Neutral $161
Nov-18-22Initiated Credit Suisse Neutral $170
Oct-18-22Initiated Barclays Equal Weight $175
May-28-24 02:15PM
07:35AM
07:30AM
06:54AM
06:00AM
08:00AM Loading…
May-27-24 08:00AM
06:00AM
05:21AM
May-26-24 07:05AM
May-25-24 07:30AM
May-24-24 05:45PM
01:00PM
12:07PM
May-23-24 03:41PM
03:23PM
01:40PM Loading…
01:40PM
May-22-24 05:22PM
05:17PM
03:11PM
11:11AM
09:48AM
06:31AM
May-21-24 01:41PM
10:57AM
07:11AM
May-20-24 01:22PM
10:52AM
07:22AM
07:01AM
06:12AM
05:20PM Loading…
May-17-24 05:20PM
11:56AM
07:11AM
06:30AM
06:24AM
May-16-24 04:37PM
02:35PM
01:41PM
12:01PM
11:30AM
09:10AM
08:40AM
08:03AM
07:40AM
07:30AM
07:10AM
06:30AM
May-15-24 10:15AM
08:19AM
03:56AM
May-14-24 01:54PM
01:31PM
01:23PM
01:16PM
01:00PM
12:57PM
09:47AM
09:00AM
May-13-24 07:44PM
04:30PM
04:08PM
12:27PM
12:10PM
11:45AM
11:22AM
11:01AM
10:55AM
10:39AM
09:22AM
08:03AM
08:00AM
07:30AM
07:28AM
06:53AM
06:52AM
06:00AM
06:00AM
May-12-24 09:16AM
08:20AM
07:00AM
May-11-24 09:46AM
May-10-24 07:10AM
06:30AM
05:21AM
May-09-24 12:51PM
12:37PM
12:15PM
07:30AM
06:49AM
05:07AM
May-08-24 04:39PM
04:30PM
03:37PM
01:55PM
12:15PM
08:04AM
07:16AM
07:00AM
May-07-24 04:48PM
03:35PM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '24Option Exercise0.0022,255022,561May 03 04:31 PM
Broadhurst VanessaEVP, Global Corp AffairsMar 13 '24Sale162.168,8911,441,76515,043Mar 13 04:36 PM
JOHNSON & JOHNSON10% OwnerFeb 29 '24Option Exercise0.723,8552,7924,103,430Mar 06 03:42 PM
JOHNSON & JOHNSON10% OwnerFeb 16 '24Sale25.813,72596,1424,099,575Mar 06 03:42 PM
Decker Robert JVP Corporate ControllerFeb 13 '24Option Exercise0.00313019,059Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '24Option Exercise0.00408024,143Feb 15 04:53 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '24Option Exercise0.0065108,576Feb 15 04:53 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '24Option Exercise0.003,4700364,809Feb 15 04:53 PM
Hait WilliamSee RemarksFeb 13 '24Option Exercise0.00834039,074Feb 15 04:53 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13 '24Option Exercise0.009250112,550Feb 15 04:53 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '24Option Exercise0.00499013,290Feb 15 04:53 PM
Swanson James D.EVP, CIOFeb 13 '24Option Exercise0.00447014,765Feb 15 04:53 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '24Option Exercise0.001,3020155,517Feb 15 04:53 PM
Wolk Joseph JExec VP, CFOFeb 13 '24Option Exercise0.001,780069,663Feb 15 04:53 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '24Option Exercise0.00651082,599Feb 15 04:53 PM
Decker Robert JVP Corporate ControllerFeb 12 '24Option Exercise0.001,912019,269Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 12 '24Option Exercise0.0036,6180377,239Feb 14 06:36 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 12 '24Option Exercise0.0026,2020167,618Feb 14 06:36 PM
Forminard ElizabethExecutive VP, General CounselFeb 12 '24Option Exercise0.002,85908,959Feb 14 06:36 PM
Wolk Joseph JExec VP, CFOFeb 12 '24Option Exercise0.0025,835078,699Feb 14 06:36 PM
Hait WilliamSee RemarksFeb 12 '24Option Exercise0.008,932042,316Feb 14 06:36 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 12 '24Option Exercise0.004,701025,081Feb 14 06:36 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 12 '24Option Exercise0.0013,813089,014Feb 14 06:36 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 12 '24Option Exercise0.005,736015,678Feb 14 06:36 PM
Swanson James D.EVP, CIOFeb 12 '24Option Exercise0.005,456016,013Feb 14 06:36 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12 '24Option Exercise0.0014,9600118,644Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 09 '24Option Exercise90.44130,96911,844,836439,283Feb 13 05:18 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Option Exercise90.4459,3975,371,865200,813Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Sale156.2759,3979,281,969141,416Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08 '24Option Exercise0.003,7390143,329Feb 12 07:25 PM
Decker Robert JVP Corporate ControllerFeb 08 '24Option Exercise0.00655017,572Feb 12 07:24 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 08 '24Option Exercise0.001,880021,083Feb 12 07:24 PM
Hait WilliamSee RemarksFeb 08 '24Option Exercise0.003,059034,497Feb 12 07:24 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08 '24Option Exercise0.002,1350104,465Feb 12 07:24 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 08 '24Option Exercise0.001,964010,943Feb 12 07:24 PM
Swanson James D.See RemarksFeb 08 '24Option Exercise0.001,868011,111Feb 12 07:24 PM
Forminard ElizabethExecutive VP, General CounselFeb 08 '24Option Exercise0.0097906,463Feb 12 07:24 PM
Wolk Joseph JExec VP, CFOFeb 08 '24Option Exercise0.003,686053,911Feb 12 07:25 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 08 '24Option Exercise0.001,971067,905Feb 12 07:25 PM
Duato JoaquinCEO and Chairman of the BoardFeb 08 '24Option Exercise0.005,2250310,583Feb 12 07:25 PM
Hait WilliamSee RemarksJul 26 '23Option Exercise90.4414,6981,329,287102,445Jul 27 05:52 PM
Hait WilliamSee RemarksJul 26 '23Sale172.0014,6982,528,05687,747Jul 27 05:52 PM
Fasolo PeterExec VP, Chief HR OfficerJul 25 '23Sale170.3220,0003,406,498102,696Jul 27 05:52 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerJun 12 '23Sale160.0012,4651,994,40065,934Jun 14 04:19 PM